<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>http://pasen.chat/wiki/index.php?action=history&amp;feed=atom&amp;title=Wikipedia_The_Free_Encyclopedia.</id>
	<title>Wikipedia The Free Encyclopedia. - Revision history</title>
	<link rel="self" type="application/atom+xml" href="http://pasen.chat/wiki/index.php?action=history&amp;feed=atom&amp;title=Wikipedia_The_Free_Encyclopedia."/>
	<link rel="alternate" type="text/html" href="http://pasen.chat/wiki/index.php?title=Wikipedia_The_Free_Encyclopedia.&amp;action=history"/>
	<updated>2026-05-02T10:09:49Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.39.1</generator>
	<entry>
		<id>http://pasen.chat/wiki/index.php?title=Wikipedia_The_Free_Encyclopedia.&amp;diff=53941&amp;oldid=prev</id>
		<title>JacksonMancia at 12:54, 20 July 2024</title>
		<link rel="alternate" type="text/html" href="http://pasen.chat/wiki/index.php?title=Wikipedia_The_Free_Encyclopedia.&amp;diff=53941&amp;oldid=prev"/>
		<updated>2024-07-20T12:54:24Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 12:54, 20 July 2024&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;
  &lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;
  &lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;−&lt;/td&gt;
  &lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Before starting SABRIL, tell&lt;/del&gt; your &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;physician&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;regarding&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;every&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;one&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;of your&lt;/del&gt; (or your &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;kid's&lt;/del&gt;) &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;medical&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;conditions&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;including&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;anxiety&lt;/del&gt;, &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;mood&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;problems&lt;/del&gt;, &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;suicidal&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;ideas&lt;/del&gt; [https://atavi.com/share/&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;wqynd2z9lnor&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Vigabatrin&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;rems&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;patient&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;enrollment&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;form]&lt;/del&gt; or &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;behavior,&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;any&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;kind&lt;/del&gt; of &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;allergy&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;to&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;SABRIL,&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;vision&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;problems,&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;kidney&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;troubles,&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;reduced&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;red&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;blood&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;cell&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;matters&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;(anemia),&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;and&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;any&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;mental&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;or&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;nervous&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;disease&lt;/del&gt;.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;The&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Vigabatrin&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;REMS&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Program&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;is&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;needed&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;by&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;the&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;FDA&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;to&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;make&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;certain&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;informed&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;risk-benefit&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;choices&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;before&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;launching&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;therapy,&lt;/del&gt; and &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;to&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;make&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;certain&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;proper&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;use&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;vigabatrin&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;while&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;individuals&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;are&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;treated.&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;It&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;is&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;not&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;feasible&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;for&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;your&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;doctor&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;to&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;understand&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;when&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;vision&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;loss&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;will&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;certainly&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;take&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;place&lt;/del&gt;. &amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;The&lt;/del&gt; most &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;common&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;negative&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;effects&lt;/del&gt; of SABRIL in &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;children&lt;/del&gt; 3 to 16 years is weight gain. With severe vision loss, you &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;might&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;just&lt;/del&gt; be able to see points &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;right&lt;/del&gt; in front of you (&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;sometimes&lt;/del&gt; called tunnel vision&quot;). You are at &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;risk&lt;/del&gt; for vision loss with any&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt; kind of&lt;/del&gt; amount of SABRIL.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Inform&lt;/del&gt; your &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;healthcare&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;provider&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;today&lt;/del&gt; if seizures get worse. You and your &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;doctor&lt;/del&gt; will &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;certainly have&lt;/del&gt; to &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;determine&lt;/del&gt; if you &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;ought&lt;/del&gt; to take SABRIL while you are &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;expectant&lt;/del&gt;. The most &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;typical&lt;/del&gt; adverse effects of SABRIL in &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;adults&lt;/del&gt; consist of: obscured vision, sleepiness, &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;dizziness&lt;/del&gt;, problems &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;strolling&lt;/del&gt; or feeling &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;uncoordinated&lt;/del&gt;, drinking (shake), and &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;exhaustion&lt;/del&gt;.&lt;/div&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;+&lt;/td&gt;
  &lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Tell&lt;/ins&gt; your &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;doctor&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;right&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;away&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;if&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;you&lt;/ins&gt; (or your &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;child&lt;/ins&gt;)&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;:&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;may&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;not&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;be viewing as well as before beginning SABRIL; start to&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;journey&lt;/ins&gt;, &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;encounter&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;points&lt;/ins&gt;, &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;or&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;are a lot more clumsy than common&lt;/ins&gt; [https://atavi.com/share/&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;wqr9kpz90ed0&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;vigabatrin&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;negative&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;effects];&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;are&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;surprised by individuals&lt;/ins&gt; or &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;points&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;being&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;available in front&lt;/ins&gt; of &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;you&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;that&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;appear&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;to&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;find&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;out&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;of&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;no&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;place;&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;or&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;if&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;your&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;child&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;is&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;acting&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;in&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;different&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;ways&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;than normal&lt;/ins&gt;.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;SABRIL&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;(vigabatrin)&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;is&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;a&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;prescription&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;medicine&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;made&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;use&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;of&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;with&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;other&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;treatments&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;in&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;adults&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;and&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;children&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;2&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;years old&lt;/ins&gt; and &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;older&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;with&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;refractory&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;facility&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;partial&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;seizures&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;(CPS)&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;who&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;have&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;not&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;reacted&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;well&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;enough&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;to&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;a&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;number&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;of&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;various&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;other&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;therapies&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;and&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;if&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;the&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;feasible&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;advantages&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;exceed the threat of vision loss&lt;/ins&gt;. &amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;One of the&lt;/ins&gt; most &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;usual&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;side&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;effect&lt;/ins&gt; of SABRIL in &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;kids&lt;/ins&gt; 3 to 16 years is weight gain. With severe vision loss, you &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;may&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;only&lt;/ins&gt; be able to see points &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;directly&lt;/ins&gt; in front of you (&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;occasionally&lt;/ins&gt; called tunnel vision&quot;). You are at &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;threat&lt;/ins&gt; for vision loss with any amount of SABRIL.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Tell&lt;/ins&gt; your &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;doctor&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;right&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;now&lt;/ins&gt; if seizures get worse. You and your &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;healthcare provider&lt;/ins&gt; will &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;need&lt;/ins&gt; to &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;choose&lt;/ins&gt; if you &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;need&lt;/ins&gt; to take SABRIL while you are &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;pregnant&lt;/ins&gt;. The most &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;usual&lt;/ins&gt; adverse effects of SABRIL in &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;grownups&lt;/ins&gt; consist of: obscured vision, sleepiness, &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;lightheadedness&lt;/ins&gt;, problems &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;walking&lt;/ins&gt; or feeling &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;unskillful&lt;/ins&gt;, drinking (shake), and &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;fatigue&lt;/ins&gt;.&lt;/div&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>JacksonMancia</name></author>
	</entry>
	<entry>
		<id>http://pasen.chat/wiki/index.php?title=Wikipedia_The_Free_Encyclopedia.&amp;diff=53548&amp;oldid=prev</id>
		<title>ChristiBeaurepai at 21:49, 19 July 2024</title>
		<link rel="alternate" type="text/html" href="http://pasen.chat/wiki/index.php?title=Wikipedia_The_Free_Encyclopedia.&amp;diff=53548&amp;oldid=prev"/>
		<updated>2024-07-19T21:49:11Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 21:49, 19 July 2024&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;
  &lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;
  &lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td colspan=&quot;2&quot; class=&quot;diff-empty&quot;&gt;&amp;#160;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;+&lt;/td&gt;
  &lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Before starting SABRIL, tell your physician regarding every one of your (or your kid's) medical conditions including anxiety, mood problems, suicidal ideas [https://atavi.com/share/wqynd2z9lnor Vigabatrin rems patient enrollment form] or behavior, any kind of allergy to SABRIL, vision problems, kidney troubles, reduced red blood cell matters (anemia), and any mental or nervous disease.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;The Vigabatrin REMS Program is needed by the FDA to make certain informed risk-benefit choices before launching therapy, and to make certain proper use vigabatrin while individuals are treated. It is not feasible for your doctor to understand when vision loss will certainly take place. &amp;lt;br&amp;gt;&amp;lt;br&amp;gt;The most common negative effects of SABRIL in children 3 to 16 years is weight gain. With severe vision loss, you might just be able to see points right in front of you (sometimes called tunnel vision&quot;). You are at risk for vision loss with any kind of amount of SABRIL.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Inform your healthcare provider today if seizures get worse. You and your doctor will certainly have to determine if you ought to take SABRIL while you are expectant. The most typical adverse effects of SABRIL in adults consist of: obscured vision, sleepiness, dizziness, problems strolling or feeling uncoordinated, drinking (shake), and exhaustion.&lt;/div&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;−&lt;/td&gt;
  &lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;The COMEX, a branch of the Chicago Mercantile Exchange, plays a pivotal duty in setting the silver place cost, using futures agreements [https://www.symbaloo.com/embed/shared/AAAAB546cu8AA42ASTwgWw== silver price per gram in rupees] to project silver costs. The highest possible optimal of silver rates was around $49.45 per troy ounce in January 1980.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Yet capitalists deal with ongoing yearly cost ratios and feasible monitoring mistakes relative to the place price of silver. The cost of silver opened up at $24.74 per ounce, since 9 a.m. ET. That's up 0.16% from the previous day's silver price per ounce and up 3.39% because the beginning of the year.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;But comparable to gold, silver costs can be offered in troy ounces, kilos and grams. The spot silver rate reflects what investors market and buy silver for instantly, or instantly. Despite this sharp rise, the rates dropped back down, and by the late 1980s, silver was trading under $10 per ounce again.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;This direct approach includes having physical silver bars and coins. Silver rounds are readily available primarily from personal mints in the USA and all over the world. Although gold remains the king of rare-earth elements for millions of capitalists, silver is a silent hero that many investors turn to for variety and cost.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;The high ratio suggests that gold is a lot more pricey than silver, suggesting a market choice for gold as a place, which can indicate economic unpredictability. Significantly, a troy ounce, the common device for pricing quote silver costs, is slightly larger than a basic ounce, with one troy ounce equating to 31.103 grams or 1.097 ounces.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;The COMEX, a branch of the Chicago Mercantile Exchange, plays a crucial function in establishing the silver spot rate, using futures agreements to task silver rates. The greatest peak of silver prices was around $49.45 per troy ounce in January 1980.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;The Great Economic downturn marked an additional substantial duration for silver prices. It's likewise important to comprehend that investments in silver can experience multiyear troughs and may not always line up with broader market fads or inflationary stress.&lt;/div&gt;&lt;/td&gt;
  &lt;td colspan=&quot;2&quot; class=&quot;diff-empty&quot;&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>ChristiBeaurepai</name></author>
	</entry>
	<entry>
		<id>http://pasen.chat/wiki/index.php?title=Wikipedia_The_Free_Encyclopedia.&amp;diff=51177&amp;oldid=prev</id>
		<title>BrigidaPlowman5: Created page with &quot;The COMEX, a branch of the Chicago Mercantile Exchange, plays a pivotal duty in setting the silver place cost, using futures agreements [https://www.symbaloo.com/embed/shared/AAAAB546cu8AA42ASTwgWw== silver price per gram in rupees] to project silver costs. The highest possible optimal of silver rates was around $49.45 per troy ounce in January 1980.&lt;br&gt;&lt;br&gt;Yet capitalists deal with ongoing yearly cost ratios and feasible monitoring mistakes relative to the place price o...&quot;</title>
		<link rel="alternate" type="text/html" href="http://pasen.chat/wiki/index.php?title=Wikipedia_The_Free_Encyclopedia.&amp;diff=51177&amp;oldid=prev"/>
		<updated>2024-07-13T11:03:36Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;The COMEX, a branch of the Chicago Mercantile Exchange, plays a pivotal duty in setting the silver place cost, using futures agreements [https://www.symbaloo.com/embed/shared/AAAAB546cu8AA42ASTwgWw== silver price per gram in rupees] to project silver costs. The highest possible optimal of silver rates was around $49.45 per troy ounce in January 1980.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Yet capitalists deal with ongoing yearly cost ratios and feasible monitoring mistakes relative to the place price o...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;The COMEX, a branch of the Chicago Mercantile Exchange, plays a pivotal duty in setting the silver place cost, using futures agreements [https://www.symbaloo.com/embed/shared/AAAAB546cu8AA42ASTwgWw== silver price per gram in rupees] to project silver costs. The highest possible optimal of silver rates was around $49.45 per troy ounce in January 1980.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Yet capitalists deal with ongoing yearly cost ratios and feasible monitoring mistakes relative to the place price of silver. The cost of silver opened up at $24.74 per ounce, since 9 a.m. ET. That's up 0.16% from the previous day's silver price per ounce and up 3.39% because the beginning of the year.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;But comparable to gold, silver costs can be offered in troy ounces, kilos and grams. The spot silver rate reflects what investors market and buy silver for instantly, or instantly. Despite this sharp rise, the rates dropped back down, and by the late 1980s, silver was trading under $10 per ounce again.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;This direct approach includes having physical silver bars and coins. Silver rounds are readily available primarily from personal mints in the USA and all over the world. Although gold remains the king of rare-earth elements for millions of capitalists, silver is a silent hero that many investors turn to for variety and cost.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;The high ratio suggests that gold is a lot more pricey than silver, suggesting a market choice for gold as a place, which can indicate economic unpredictability. Significantly, a troy ounce, the common device for pricing quote silver costs, is slightly larger than a basic ounce, with one troy ounce equating to 31.103 grams or 1.097 ounces.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;The COMEX, a branch of the Chicago Mercantile Exchange, plays a crucial function in establishing the silver spot rate, using futures agreements to task silver rates. The greatest peak of silver prices was around $49.45 per troy ounce in January 1980.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;The Great Economic downturn marked an additional substantial duration for silver prices. It's likewise important to comprehend that investments in silver can experience multiyear troughs and may not always line up with broader market fads or inflationary stress.&lt;/div&gt;</summary>
		<author><name>BrigidaPlowman5</name></author>
	</entry>
</feed>